首页 | 本学科首页   官方微博 | 高级检索  
     


Prognostic Index for Survival in Patients After Treatment for Primary Hepatocellular Carcinoma
Authors:Mari Kogo  Ayuko Kano  Yuji Kiuchi  Keiji Mitamura  Keiichiro Yoneyama
Affiliation:(1) Department of Pathophysiology, Showa University School of Pharmaceutical Sciences, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan;(2) Second Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan;(3) Health Service Center, Showa University, Tokyo, Japan
Abstract:We retrospectively evaluated clinical factors affecting long-term survival after treatment for hepatocellular carcinoma (HCC) to predict the reliability of the prognosis of patients with HCC. We analyzed 157 patients who received treatment for HCC. The prognostic index (PI) was evaluated using the Cox regression model. The overall cumulative survival rates were 79.7% at 1 year, 51.1% at 3 years, and 24.9% at 5 years. The PI was calculated by the following formula, consisting of five factors: PI=0.637×number of tumor lesions+0.103×tumor diameter+1.003×ascites+0.915×portal vein tumor thrombosis – 0.006×cholinesterase+2.0. It was found that liver function and progression of the tumor are the most important factors for prognosis after treatment for HCC. The PI, based on five factors, will in future be an appropriate index to predict the prognosis of patients with HCC.
Keywords:Hepatocellular carcinoma  Transcatheter arterial embolization  Percutaneous ethanol injection  Multivariate analysis  Prognostic index
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号